Experimental Molecule Shows Promise for Long-Term Asthma Treatment in Mice

For the roughly 25 million Americans who live with asthma, modern medicine has long offered management but never a cure — treating the storm without addressing the damage it leaves behind. Researchers at Aston University have now identified a molecule that may change that calculus, targeting not the symptoms of asthma but the structural remodeling of the airways that makes the disease a permanent condition. In asthmatic mice, the compound reversed that damage within weeks — a result that, while still far from the clinic, asks a question medicine has rarely been able to pose: what if we could u